US2007203326A1PendingUtilityA1
Integrin-linked kinase and its uses
Est. expiryDec 21, 2015(expired)· nominal 20-yr term from priority
G01N 2333/9121C12N 9/1205G01N 2333/70546A61K 38/00C12N 9/12C12Q 1/48
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
Claims
exact text as granted — not AI-modified1 .- 21 . (canceled)
22 . A purified polypeptide composition comprising at least 50% by weight of the protein present as integrin linked kinase, wherein said polypeptide is encoded by an isolated nucleic acid that will hybridize to the nucleotide sequence set forth in SEQ ID NO:22 under the following conditions: 0.1×SSC (9 mM saline/0.9 mM sodium citrate) at 50° C. or higher.Join the waitlist — get patent alerts
Track US2007203326A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.